{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:04:09Z","timestamp":1751353449421,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s00066-023-02054-0","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T13:02:56Z","timestamp":1677762176000},"page":"420-424","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Stereotactic ablative radiotherapy for unresectable inferior vena cava tumor thrombus in a\u00a0patient with renal cell carcinoma: a\u00a0case report"],"prefix":"10.1007","volume":"199","author":[{"given":"Pauline","family":"Castelnau-Marchand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1221-4076","authenticated-orcid":false,"given":"Nathaniel","family":"Scher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Bollet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrus","family":"Chargari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Toledano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,2]]},"reference":[{"key":"2054_CR1","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1097\/01.ju.0000096060.92397.ed","volume":"170","author":"WM Linehan","year":"2003","unstructured":"Linehan\u00a0WM, Walther\u00a0MM, Zbar\u00a0B (2003) The genetic basis of cancer of the kidney. J\u00a0Urol 170:2163\u20132172","journal-title":"J Urol"},{"key":"2054_CR2","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1200\/JCO.1994.12.1.206","volume":"12","author":"RA Rabinovitch","year":"1994","unstructured":"Rabinovitch\u00a0RA, Zelefsky\u00a0MJ, Gaynor\u00a0JJ, Fuks\u00a0Z (1994) Patterns of failure following surgical resection of renal cell carcinoma: Implications for adjuvant local and systemic therapy. J\u00a0Clin Oncol 12:206\u2013212","journal-title":"J Clin Oncol"},{"key":"2054_CR3","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S0090-4295(99)80346-X","volume":"46","author":"SC Cozad","year":"1995","unstructured":"Cozad\u00a0SC, Smalley\u00a0SR, Austenfeld\u00a0M, Noble\u00a0M, Jennings\u00a0S, Raymond\u00a0R (1995) Transitional cell carcinoma of the renal pelvis or ureter: patterns of failure. Urology 46:796\u2013800","journal-title":"Urology"},{"key":"2054_CR4","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1056\/NEJMoa1712126","volume":"378","author":"RJ Motzer","year":"2018","unstructured":"Motzer\u00a0RJ, Tannir\u00a0NM, McDermott\u00a0DF, Frontera\u00a0AO, Melichar\u00a0B, Choueiri\u00a0TK, Plimack\u00a0ER, Barth\u00e9l\u00e9my\u00a0P, Porta\u00a0C, George\u00a0S et al (2018) Nivolumab plus Ipilimumab versus sunitinib in advanced renal-cell carcinoma. N\u00a0Engl J Med 378:1277\u20131290","journal-title":"N Engl J Med"},{"key":"2054_CR5","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1056\/NEJMoa1816714","volume":"380","author":"BI Rini","year":"2019","unstructured":"Rini\u00a0BI, Plimack\u00a0ER, Stus\u00a0V, Gafanov\u00a0R, Hawkins\u00a0R, Nosov\u00a0D, Pouliot\u00a0F, Alekseev\u00a0B, Souli\u00e8res\u00a0D, Melichar\u00a0B et al (2019) Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma. N\u00a0Engl J Med 380:1116\u20131127","journal-title":"N Engl J Med"},{"issue":"6","key":"2054_CR6","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.euo.2018.10.005","volume":"2","author":"Y Freifeld","year":"2019","unstructured":"Freifeld\u00a0Y, Woldu\u00a0SL, Singla\u00a0N, Clinton\u00a0T, Bagrodia\u00a0A, Hutchinson\u00a0R et\u00a0al (2019) Impact of hospital case volume on outcomes following radical nephrectomy and inferior vena cava thrombectomy. Eur Urol Oncol 2(6):691\u2013698","journal-title":"Eur Urol Oncol"},{"key":"2054_CR7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa065044","author":"RJ Motzer","year":"2007","unstructured":"Motzer\u00a0RJ, Bukowski\u00a0RM, Szczylik\u00a0C, Baum\u00a0CM (2007) Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N\u00a0Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa065044","journal-title":"N Engl J Med"},{"issue":"1","key":"2054_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40644-018-0150-z","volume":"18","author":"LC Adams","year":"2018","unstructured":"Adams\u00a0LC, Ralla\u00a0B, Bender\u00a0Y\u2011NY, Bressem\u00a0K, Hamm\u00a0B, Busch\u00a0J et al (2018) Renal cell carcinoma with venous extension: prediction of inferior vena cava wall invasion by MRI. Cancer Imaging 18(1):17\u201313","journal-title":"Cancer Imaging"},{"issue":"5","key":"2054_CR9","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.eururo.2017.08.019","volume":"73","author":"A Nini","year":"2018","unstructured":"Nini\u00a0A, Capitanio\u00a0U, Larcher\u00a0A, Dell\u2019Oglio\u00a0P, Deh\u00f2\u00a0F, Suardi\u00a0N et\u00a0al (2018) Perioperative and oncologic outcomes of nephrectomy and caval thrombectomy using extracorporeal circulation and deep hypothermic circulatory arrest for renal cell carcinoma invading the Supradiaphragmatic inferior Vena Cava and\/or right atrium. Eur Urol 73(5):793\u2013799","journal-title":"Eur Urol"},{"issue":"1","key":"2054_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ijrobp.2017.01.032","volume":"98","author":"CJ Wang","year":"2017","unstructured":"Wang\u00a0CJ, Christie\u00a0A, Lin\u00a0M\u2011H, Jung\u00a0M, Weix\u00a0D, Huelsmann\u00a0L et al (2017) Safety and efficacy of stereotactic ablative radiation therapy for renal cell carcinoma extracranial metastases. Int J Radiat Oncol Biol Phys 98(1):91\u2013100","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2054_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2021.01.054.","author":"V Margulis","year":"2021","unstructured":"Margulis\u00a0V, Freifeld\u00a0Y, Pop\u00a0LM, Manna\u00a0S, Kapur\u00a0P, Pedrosa\u00a0I et al (2021) Neoadjuvant SABR for renal cell carcinoma inferior vena cava tumor thrombus-safety lead-in results of a\u00a0phase 2 trial. Int J Radiat Oncol Biol Phys. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.01.054","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"2054_CR12","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.ijrobp.2011.12.024","volume":"84","author":"J-Z Hou","year":"2012","unstructured":"Hou\u00a0J\u2011Z, Zeng\u00a0Z\u2011C, Zhang\u00a0J\u2011Y, Fan\u00a0J, Zhou\u00a0J, Zeng\u00a0M\u2011S (2012) Influence of tumor thrombus location on the outcome of external-beam radiation therapy in advanced hepatocellular carcinoma with macrovascular invasion. Int J Radiat Oncol Biol Phys 84(2):362\u2013368","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2054_CR13","first-page":"388.e1","volume":"33","author":"AQ Haddad","year":"2015","unstructured":"Haddad\u00a0AQ, Leibovich\u00a0BC, Abel\u00a0EJ, Luo\u00a0J\u2011H, Krabbe\u00a0L\u2011M, Thompson\u00a0RH, Heckman\u00a0JE, Merrill\u00a0MM, Gayed\u00a0BA, Sagalowsky\u00a0AI et al (2015) Preoperative multivariable prognostic models for prediction of survival and major complications following surgical resection of renal cell carcinoma with suprahepatic caval tumor thrombus. Urol Oncol Semin Orig Investig 33:388.e1\u2013388.e9","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"2054_CR14","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.ijrobp.2013.12.050","volume":"88","author":"S Stanic","year":"2014","unstructured":"Stanic\u00a0S, Paulus\u00a0R, Timmerman\u00a0RD, Michalski\u00a0JM, Barriger\u00a0RB, Bezjak\u00a0A, Videtic\u00a0GM, Bradley\u00a0J (2014) No clinically significant changes in pulmonary function following stereotactic body radiation therapy for early-stage peripheral non-small cell lung cancer: an analysis of RTOG 0236. Int J Radiat Oncol 88:1092\u20131099","journal-title":"Int J Radiat Oncol"},{"key":"2054_CR15","doi-asserted-by":"publisher","unstructured":"Timmerman R (2022) A Story of Hypofractionation and the Table on the Wall. Int J Radiat Oncol Biol Phys. 2022 Jan 1;112(1):4\u201321. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.09.027. PMID: 34919882.","DOI":"10.1016\/j.ijrobp.2021.09.027"},{"key":"2054_CR16","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1200\/JCO.2010.31.4377","volume":"29","author":"TP Boike","year":"2011","unstructured":"Boike\u00a0TP, Lotan\u00a0Y, Cho\u00a0LC, Brindle\u00a0J, Derose\u00a0P, Xie\u00a0X\u2011J, Yan\u00a0J, Foster\u00a0R, Pistenmaa\u00a0D, Perkins\u00a0A et al (2011) Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer. J\u00a0Clin Oncol 29:2020\u20132026","journal-title":"J Clin Oncol"},{"key":"2054_CR17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.prro.2013.05.001","volume":"4","author":"S Ryu","year":"2014","unstructured":"Ryu\u00a0S, Pugh\u00a0SL, Gerszten\u00a0PC, Yin\u00a0F\u2011F, Timmerman\u00a0RD, Hitchcock\u00a0YJ, Movsas\u00a0B, Kanner\u00a0AA, Berk\u00a0LB, Followill\u00a0DS et al (2014) RTOG 0631 phase 2\/3\u00a0study of image guided stereotactic radiosurgery for localized (1\u20133) spine metastases: phase 2 results. Pract Radiat Oncol 4:76\u201381","journal-title":"Pract Radiat Oncol"},{"key":"2054_CR18","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1002\/(SICI)1097-0142(19971215)80:12+<2519::AID-CNCR26>3.0.CO;2-E","volume":"80","author":"S Ning","year":"1997","unstructured":"Ning\u00a0S, Trisler\u00a0K, Wessels\u00a0BW, Knox\u00a0SJ (1997) Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts. Cancer 80:2519\u20132528","journal-title":"Cancer"},{"key":"2054_CR19","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.eururo.2006.03.021","volume":"50","author":"L Walsh","year":"2006","unstructured":"Walsh\u00a0L, Stanfield\u00a0JL, Cho\u00a0LC, Chang\u00a0CH, Forster\u00a0K, Kabbani\u00a0W, Cadeddu\u00a0JA, Hsieh\u00a0JT, Choy\u00a0H, Timmerman\u00a0R et al (2006) Efficacy of ablative high-dose-per-fraction radiation for implanted human renal cell cancer in a\u00a0nude mouse model. Eur Urol 50:795\u2013800","journal-title":"Eur Urol"},{"key":"2054_CR20","doi-asserted-by":"publisher","first-page":"e170","DOI":"10.1016\/S1470-2045(13)70569-2","volume":"15","author":"G De Meerleer","year":"2014","unstructured":"De Meerleer\u00a0G, Khoo\u00a0V, Escudier\u00a0B, Joniau\u00a0S, Bossi\u00a0A, Ost\u00a0P, Briganti\u00a0A, Fonteyne\u00a0V, Van Vulpen\u00a0M, Lumen\u00a0N et al (2014) Radiotherapy for renal-cell carcinoma. Lancet Oncol 15:e170\u2013e177","journal-title":"Lancet Oncol"},{"issue":"5","key":"2054_CR21","doi-asserted-by":"publisher","first-page":"e63864","DOI":"10.1371\/journal.pone.0063864","volume":"8","author":"M Xi","year":"2013","unstructured":"Xi\u00a0M, Zhang\u00a0L, Zhao\u00a0L, Li\u00a0Q\u2011Q, Guo\u00a0S\u2011P, Feng\u00a0Z\u2011Z et al (2013) Effectiveness of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein and\/or inferior vena cava tumor thrombosis. Plos One 8(5):e63864","journal-title":"Plos One"},{"key":"2054_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/jrr\/rrw028","author":"Y Matsuo","year":"2016","unstructured":"Matsuo\u00a0Y, Yoshida\u00a0K, Nishimura\u00a0H, Ejima\u00a0Y, Miyawaki\u00a0D, Uezono\u00a0H et al (2016) Efficacy of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis\/inferior vena cava tumor thrombosis: evaluation by comparison with conventional three-dimensional conformal radiotherapy. J Radiat Res. https:\/\/doi.org\/10.1093\/jrr\/rrw028","journal-title":"J. Radiat. Res."},{"issue":"1","key":"2054_CR23","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s13014-018-1136-5","volume":"13","author":"Y Shui","year":"2018","unstructured":"Shui\u00a0Y, Yu\u00a0W, Ren\u00a0X, Guo\u00a0Y, Xu\u00a0J, Ma\u00a0T et\u00a0al (2018) Stereotactic body radiotherapy based treatment for hepatocellular carcinoma with extensive portal vein tumor thrombosis. Radiat Oncol 13(1):188","journal-title":"Radiat Oncol"},{"issue":"8","key":"2054_CR24","doi-asserted-by":"publisher","first-page":"e452","DOI":"10.1016\/S1470-2045(19)30171-8","volume":"20","author":"E Deutsch","year":"2019","unstructured":"Deutsch\u00a0E, Chargari\u00a0C, Galluzzi\u00a0L, Kroemer\u00a0G (2019) Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy. Lancet Oncol 20(8):e452\u2013e463","journal-title":"Lancet Oncol"},{"key":"2054_CR25","first-page":"166.e9","volume":"40","author":"Y Freifeld","year":"2022","unstructured":"Freifeld\u00a0Y, Pedrosa\u00a0I, Mclaughlin\u00a0M, Correa\u00a0RM, Louie\u00a0AV, Maldonado\u00a0JA, Tang\u00a0C, Kadow\u00a0B, Kutikov\u00a0A, Uzzo\u00a0RG et\u00a0al (2022) Stereotactic ablative radiation therapy for renal cell carcinoma with inferior vena cava tumor thrombus. Urol Oncol Semin Orig Investig 40:166.e9\u2013166.e13","journal-title":"Urol Oncol Semin Orig Investig"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-023-02054-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-023-02054-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-023-02054-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T23:03:28Z","timestamp":1679526208000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-023-02054-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,2]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["2054"],"URL":"https:\/\/doi.org\/10.1007\/s00066-023-02054-0","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"type":"print","value":"0179-7158"},{"type":"electronic","value":"1439-099X"}],"subject":[],"published":{"date-parts":[[2023,3,2]]},"assertion":[{"value":"26 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.\u00a0Castelnau-Marchand, N.\u00a0Scher, M.\u00a0Bollet, C.\u00a0Chargari, and A.\u00a0Toledano declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}